BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36281887)

  • 21. Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
    Lorentino F; Labopin M; Bernardi M; Ciceri F; Socié G; Cornelissen JJ; Esteve J; Ruggeri A; Volin L; Yacoub-Agha I; Craddock C; Passweg J; Blaise D; Gedde-Dahl T; Poiani M; Fegueux N; Mohty M; Nagler A;
    Am J Hematol; 2018 Oct; 93(10):1236-1244. PubMed ID: 30058714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
    Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M
    Bone Marrow Transplant; 2022 Nov; 57(11):1657-1663. PubMed ID: 35978005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia.
    Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y;
    Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China.
    Gao L; Wen Q; Chen X; Liu Y; Zhang C; Gao L; Kong P; Zhang Y; Li Y; Liu J; Wang Q; Su Y; Wang C; Wang S; Zeng Y; Sun A; Du X; Zeng D; Liu H; Peng X; Zhang X
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1932-9. PubMed ID: 25109850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.
    Mizuno S; Takami A; Kawamura K; Shimomura Y; Arai Y; Konuma T; Ozawa Y; Sawa M; Ota S; Takahashi S; Anzai N; Hiramoto N; Onizuka M; Nakamae H; Tanaka M; Murata M; Kimura T; Kanda J; Fukuda T; Atsuta Y; Yanada M
    Transplant Cell Ther; 2022 Nov; 28(11):775.e1-775.e9. PubMed ID: 35921987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haploidentical haematopoietic stem cell transplantation for TP53-mutated acute myeloid leukaemia.
    Huang T; Xu L; Zhang X; Chang Y; Mo X; Sun Y; Huang X; Wang Y
    Br J Haematol; 2023 Feb; 200(4):494-505. PubMed ID: 36345800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.
    Ruggeri A; Labopin M; Sanz G; Piemontese S; Arcese W; Bacigalupo A; Blaise D; Bosi A; Huang H; Karakasis D; Koc Y; Michallet M; Picardi A; Sanz J; Santarone S; Sengelov H; Sierra J; Vincent L; Volt F; Nagler A; Gluckman E; Ciceri F; Rocha V; Mohty M; ;
    Leukemia; 2015 Sep; 29(9):1891-900. PubMed ID: 25882700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.
    Mo XD; Tang BL; Zhang XH; Zheng CC; Xu LP; Zhu XY; Wang Y; Liu HL; Yan CH; Chu XD; Chen H; Geng LQ; Liu KY; Sun ZM; Huang XJ
    Int J Cancer; 2016 Nov; 139(9):2106-15. PubMed ID: 27356906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
    Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation.
    Zhou B; Xu M; Lu S; Liu Y; Qi L; Liu T; Tian H; Chen J; Wu D; Xu Y
    Transplant Cell Ther; 2022 Mar; 28(3):173.e1-173.e6. PubMed ID: 34954150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
    Rocha V; Arcuri LJ; Seber A; Colturato V; Zecchin VG; Kuwahara C; Nichele S; Gouveia R; Fernandes JF; Macedo AV; Tavares R; Daudt L; De Souza MP; Darrigo-Jr LG; Villela NC; Mariano LCB; Ginani VC; Zanette A; Loth G; Gomes AA; Hamerschlak N; Flowers ME; Bonfim C;
    Bone Marrow Transplant; 2021 Dec; 56(12):3042-3048. PubMed ID: 34548627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
    Bailén R; Pascual-Cascón MJ; Guerreiro M; López-Corral L; Chinea A; Bermúdez A; Sampol A; Heras I; García-Torres E; Torres M; Roca JR; Herruzo B; Sanz J; Fonseca M; Herrera P; Colorado M; Bento L; López-Godino O; Martín-Calvo C; Fernández-Caldas P; Marcos-Jubilar M; Sánchez-Ortega I; Solano C; Noriega V; Humala K; Oarbeascoa G; Díez-Martín JL; Kwon M;
    Transplant Cell Ther; 2022 Apr; 28(4):204.e1-204.e10. PubMed ID: 35108627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia.
    Bai L; Zhang YZ; Yan CH; Wang Y; Xu LP; Zhang XH; Zhang LP; Huang XJ; Cheng YF
    BMC Cancer; 2022 Aug; 22(1):896. PubMed ID: 35974319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.
    Wagner JE; Ballen KK; Zhang MJ; Allbee-Johnson M; Karanes C; Milano F; Verneris MR; Eapen M; Brunstein CG
    Blood Adv; 2021 Oct; 5(20):4064-4072. PubMed ID: 34461630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
    Dholaria B; Labopin M; Sanz J; Ruggeri A; Cornelissen J; Labussière-Wallet H; Blaise D; Forcade E; Chevallier P; Grassi A; Zubarovskaya L; Kuball J; Ceballos P; Ciceri F; Baron F; Savani BN; Nagler A; Mohty M
    J Hematol Oncol; 2021 May; 14(1):76. PubMed ID: 33941226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT.
    Sanz J; Galimard JE; Labopin M; Afanasyev B; Angelucci E; Ciceri F; Blaise D; Cornelissen JJ; Meijer E; Diez-Martin JL; Koc Y; Rovira M; Castagna L; Savani B; Ruggeri A; Nagler A; Mohty M;
    J Hematol Oncol; 2020 May; 13(1):46. PubMed ID: 32375860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
    Lei M; Zhang Y; Jiao W; Li X; Zhou H; Wang Q; Qiu H; Tang X; Han Y; Fu C; Jin Z; Chen S; Sun A; Miao M; Liu L; Wu D
    Front Immunol; 2022; 13():912917. PubMed ID: 35812409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.